ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

NCI To Seek Cancer Act Changes On Center Grant Limits

April 9, 1976

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

Study: Molecular Breast Imaging Can Be As Effective as MRI

July 27, 2012